109 related articles for article (PubMed ID: 27699669)
1. The Human Cytochrome P450 Allele Nomenclature Committee Web Site : Submission Criteria, Procedures, and Objectives.
Sim SC; Ingelman-Sundberg M
Methods Mol Biol; 2006; 320():183-191. PubMed ID: 27699669
[TBL] [Abstract][Full Text] [Related]
2. The human cytochrome P450 Allele Nomenclature Committee Web site: submission criteria, procedures, and objectives.
Sim SC; Ingelman-Sundberg M
Methods Mol Biol; 2006; 320():183-91. PubMed ID: 16719391
[TBL] [Abstract][Full Text] [Related]
3. Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database.
Sim SC; Ingelman-Sundberg M
Methods Mol Biol; 2013; 987():251-9. PubMed ID: 23475683
[TBL] [Abstract][Full Text] [Related]
4. The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects.
Sim SC; Ingelman-Sundberg M
Hum Genomics; 2010 Apr; 4(4):278-81. PubMed ID: 20511141
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of cytochrome P450 and xenobiotic toxicity.
Ingelman-Sundberg M
Toxicology; 2002 Dec; 181-182():447-52. PubMed ID: 12505350
[TBL] [Abstract][Full Text] [Related]
6. CYPalleles: a web page for nomenclature of human cytochrome P450 alleles.
Oscarson M; Ingelman-Sundberg M
Drug Metab Pharmacokinet; 2002; 17(6):491-5. PubMed ID: 15618703
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of cytochrome P450 (CYP) in the elderly.
Seripa D; Pilotto A; Panza F; Matera MG; Pilotto A
Ageing Res Rev; 2010 Oct; 9(4):457-74. PubMed ID: 20601196
[TBL] [Abstract][Full Text] [Related]
8. Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology.
Nebert DW
Pharmacogenetics; 2000 Jun; 10(4):279-90. PubMed ID: 10862518
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
10. The Central Role of Cytochrome P450 in Xenobiotic Metabolism-A Brief Review on a Fascinating Enzyme Family.
Esteves F; Rueff J; Kranendonk M
J Xenobiot; 2021 Jun; 11(3):94-114. PubMed ID: 34206277
[TBL] [Abstract][Full Text] [Related]
11. Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy.
Preissner SC; Hoffmann MF; Preissner R; Dunkel M; Gewiess A; Preissner S
PLoS One; 2013; 8(12):e82562. PubMed ID: 24340040
[TBL] [Abstract][Full Text] [Related]
12. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
Murray M
J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
[TBL] [Abstract][Full Text] [Related]
13. Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.
Zhou Y; Ingelman-Sundberg M; Lauschke VM
Clin Pharmacol Ther; 2017 Oct; 102(4):688-700. PubMed ID: 28378927
[TBL] [Abstract][Full Text] [Related]
14. Can the genotype or phenotype of two polymorphic drug metabolising cytochrome P450-enzymes identify oral lichenoid drug eruptions?
Kragelund C; Hansen C; Reibel J; Nauntofte B; Brosen K; Jensen SB; Torpet LA
J Oral Pathol Med; 2010 Jul; 39(6):497-505. PubMed ID: 20492431
[TBL] [Abstract][Full Text] [Related]
15. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
Zanger UM; Schwab M
Pharmacol Ther; 2013 Apr; 138(1):103-41. PubMed ID: 23333322
[TBL] [Abstract][Full Text] [Related]
17. Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics.
Martinez MN; Antonovic L; Court M; Dacasto M; Fink-Gremmels J; Kukanich B; Locuson C; Mealey K; Myers MJ; Trepanier L
Drug Metab Rev; 2013 May; 45(2):218-30. PubMed ID: 23432217
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacogenetics and interindividual variability in drug response: cytochrome P-450 2C9 and coumarin anticoagulants].
Becquemont L; Verstuyft C; Jaillon P
Bull Acad Natl Med; 2006 Jan; 190(1):37-49; discussion 50-3. PubMed ID: 16878445
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 pharmacogenetics and cancer.
Rodriguez-Antona C; Ingelman-Sundberg M
Oncogene; 2006 Mar; 25(11):1679-91. PubMed ID: 16550168
[TBL] [Abstract][Full Text] [Related]
20. Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes.
Ingelman-Sundberg M
Mutat Res; 2001 Oct; 482(1-2):11-9. PubMed ID: 11535244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
